Pancreatic Neuroendocrine Tumors
625 articles
A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.
The Whys and Hows of Pancreatic Enzyme Replacement Therapy
Pancreatic enzyme replacement therapy (PERT), is an important part of treatment that is often not properly utilized, but a new tool can help.
Precursors to Pancreatic Cancer: Are There Any Signs to Watch Out For?
Dr. Venkata Akshintala outlines some of the precursors to pancreatic cancer that people should look out for.
Can a Pancreatic Cancer Screening Test Become a Reality?
Dr. Felice Schnoll-Sussman discusses screening options for pancreatic cancer and criteria for people who might want to get screened.
New Trial to Find Biomarkers to Guide Treatment
Drs. Jennifer Knox and Elizabeth Jaffee lead the PASS-01 trial using biomarkers and other measures to choose individualized treatment.
A Second Opinion: Important for Pancreatic Cancer Patients
Dr. Allyson Ocean and Dr. Jordan Winter explain why getting a second opinion can be of great benefit for pancreatic cancer patients.
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
New-Onset Diabetes Plus Unintentional Weight Loss Emerging as an Important Clue In Earlier Detection
Dr. Brian Wolpin outlines the connection between unintentional weight loss, new-onset diabetes, and pancreatic cancer.
Meet the World Pancreatic Cancer Coalition
The World Pancreatic Cancer Coalition shows there is power when advocacy groups join together for the cause: World Pancreatic Cancer Day.
Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019
Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.
A Clinical Trial for a Rare Pancreatic Cancer
Allison Lippman Kuban was trying to tolerate a difficult chemotherapy regimen when a mutation was found that qualified her for a clinical trial.
I’m a Person, Not a Diagnosis
Burt Rosen discusses his life with PNET, making sure he is a person, and more than his diagnosis.
A New Combination Targeting the RAS Pathway
Researchers are testing two new drugs that target the RAS pathway, to make standard chemotherapy more effective.
Study Reveals Molecular Differences in Young-Onset Pancreatic Cancer
There has been a notable increase in cases of young onset pancreatic cancer. Dr. Jashodeep Datta and team are exploring why this is happening.
This Is What It’s Like To Live With Pancreatic Cancer
Anne Glauber recounts her treatment for pancreatic cancer for Prevention magazine and offers insights on embracing each day and living it to its fullest.